Open Access

Erratum to: “Correction: Practical aspects in the management of hypokalemic periodic paralysis”

Journal of Translational Medicine201412:198

https://doi.org/10.1186/1479-5876-12-198

Received: 7 July 2014

Accepted: 7 July 2014

Published: 17 July 2014

The original article was published in Journal of Translational Medicine 2008 6:18

Text

After the publication of this work [1], we noticed an error in Table 1. The dosage of potassium citrate monohydrate should be 1622 mg, not 540 mg as originally stated. The corrected table is included below.
Table 1

(corrected): Potassium salts and their milligram to milliequivalent (or millimole) relationships

Spoken Name

Chemical Formula

mg

mEq K + (or mM K+)

Elemental potassium ion

K+

39.1

1

Potassium chloride (powder or tablets)

KCl

1500

20

Potassium bicarbonate (powder, tablets, or self-dissolving tablets)

KHCO3

650

6.5

Potassium citrate monohydrate

K3C6H5O7*H2O

1622

15 (i.e., 5 mEq of K3C6H5O7*H2O)

Potassium chloride 10% oral solution, 15 mL

KCl 10% oral solution

1500

20

Potassium chloride 20% oral solution, 15 mL

KCl 20% oral solution

3000

40

Potassium gluconate elixer, 15 mL

KC6H11O7

4680

20

Potassium gluconate tablets

KC6H11O7

500

2

The author apologises for this oversight.

Notes

Authors’ Affiliations

(1)
President and Medical Director, Periodic Paralysis Association
(2)
Department of Dermatology, The Mount Sinai Medical Center

References

  1. Levitt JO: Practical aspects in the management of hypokalemic periodic paralysis. J Transl Med. 2008, 6: 28-10.1186/1479-5876-6-28. doi:10.1186/1479-5876-6-18View ArticleGoogle Scholar

Copyright

© Levitt; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement